Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 44.33% vs 11.98% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 30.17% vs 18.19% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 35.93% vs 41.19% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 84.20% vs -0.04% in Mar 2024
Compare Profit and Loss Results of Raaj Medisafe
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
62.00
332.00
-270.00
-81.33%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
62.00
332.00
-270.00
-81.33%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-1.00
1.00
100.00%
Raw Materials Consumed
44.00
213.00
-169.00
-79.34%
Power & Fuel Cost
2.00
24.00
-22.00
-91.67%
Employee Cost
3.00
24.00
-21.00
-87.50%
Operating Expenses
1.00
22.00
-21.00
-95.45%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1.00
14.00
-13.00
-92.86%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
2.00
-2.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
53.00
308.00
-255.00
-82.79%
Operating Profit (PBDIT) excl Other Income
8.00
23.00
-15.00
-65.22%
Other Income
0.00
0.00
0.00
0%
Operating Profit (PBDIT)
8.00
23.00
-15.00
-65.22%
Interest
2.00
6.00
-4.00
-66.67%
Profit before Depriciation and Tax
6.00
16.00
-10.00
-62.50%
Depreciation
1.00
6.00
-5.00
-83.33%
Profit Before Taxation & Exceptional Items
5.00
10.00
-5.00
-50.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
5.00
10.00
-5.00
-50.00%
Provision for Tax
0.00
2.00
-2.00
-100.00%
Profit After Tax
6.00
7.00
-1.00
-14.29%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-2.00
56.00
-58.00
-103.57%
Profit Available for appropriations
3.00
64.00
-61.00
-95.31%
Appropriations
3.00
64.00
-61.00
-95.31%
Equity Dividend (%)
0%
2%
-2.00
Earnings Per Share
4.6
5.39
-0.79
-14.66%
Profit And Loss - Net Sales
Net Sales 62.42 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 44.33% vs 11.98% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 8.63 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 30.17% vs 18.19% in Mar 2024
Profit And Loss - Interest
Interest 2.13 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 35.93% vs 41.19% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 6.13 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 84.20% vs -0.04% in Mar 2024